Germline BRCA2 Mutation in a Patient with Fallopian Tube Carcinoma: A Case Report

By Rose P.G.   Shrigley R.   Wiesner G.L.  

Gynecologic Oncology, Vol. 77, Iss. 2, 2000-05 ,pp. : 319-320

Elsevier

Access to resources Recommend Favorite

Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers

By Domchek Susan  

Breast Cancer Research and Treatment, Vol. 124, Iss. 1, 2010-11 ,pp. : 195-203

Springer Publishing Company

Access to resources Recommend Favorite

Molecular Evidence Linking Primary Cancer of the Fallopian Tube to BRCA1 Germline Mutations

By Zweemer R.P.   van Diest P.J.   Verheijen R.H.M.   Ryan A.   Gille J.J.P.   Sijmons R.H.   Jacobs I.J.   Menko F.H.   Kenemans P.  

Gynecologic Oncology, Vol. 76, Iss. 1, 2000-01 ,pp. : 45-50

Elsevier

Access to resources Recommend Favorite

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group

By  

The Women's Oncology Review, Vol. 4, Iss. 3, 2004-09 ,pp. : 241-242

Informa Healthcare

Access to resources Recommend Favorite

Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy

By Fakkert Ingrid   Jansen Liesbeth   Meijer Kees   Kok Theo   Oosterwijk Jan   Mourits Marian   Bock Geertruida  

Breast Cancer Research and Treatment, Vol. 129, Iss. 1, 2011-08 ,pp. : 157-164

Springer Publishing Company

Access to resources Recommend Favorite